The UK Medications and Healthcare Products Regulatory Agency (MHRA) has begun a review into the safety of topiramate, which will look at possible harms in the learning and development of children whose mothers took topiramate during pregnancy.
At present, it is recommended that anyone of child bearing potential should use highly effective contraception and avoid pregnancy while taking topiramate. You should review the MRHA website regularly to remain aware of the latest advice.
If you have concerns about your use of topiramate in the light of this development, please talk to your prescribing physician.